Innovative Neurotech Focus Koniku is pioneering biologically-inspired devices that integrate living tissue with advanced technologies, creating unique opportunities for clients in neurotechnology, brain-machine interfaces, and living devices sectors.

Strategic Aerospace Partnerships Established collaborations with Airbus and European Aerospace demonstrate strong potential for supplying advanced biological and chemical hazard detection systems to the aviation industry, opening avenues for long-term security and safety solutions.

Rapid COVID-19 Detection Capabilities Koniku’s development of robotic sniffers for COVID-19 offers a quick-response solution for health authorities, which can be extended or adapted for other rapid biohazard detection applications in healthcare and safety markets.

Moderate Financial Scale With a revenue range of ($1M - $10M) and significant funding of $37M, Koniku offers a high-growth potential company that can benefit from strategic investments and partnerships to expand its innovative product offerings.

Emerging Market Position As a leader in neurotechnology with a niche focus on biological sensing and threat detection, Koniku is positioned to capitalize on growing security, health, and aerospace markets seeking advanced, bio-inspired solutions.